| 人血白蛋白临床应用调查及合理性分析 |
| |
| 引用本文： | 杭永付,郑晓娴,张 彦,李 芸,秦 琼,龚晓英,包健安,金鸿宾. 人血白蛋白临床应用调查及合理性分析[J]. 药学与临床研究, 2015, 23(6): 581-583 |
| |
| 作者姓名： | 杭永付 郑晓娴 张 彦 李 芸 秦 琼 龚晓英 包健安 金鸿宾 |
| |
| 作者单位： | 苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006,苏州大学附属第一医院药学部，苏州 215006 |
| |
| 基金项目： | 江苏省药学会-百特生物药学基金项目（JS2012-02） |
| |
| 摘 要： | 目的：调查某院人血白蛋白使用情况，为建立人血白蛋白合理使用管控体系提供依据和参考。方法：回顾性调查2013年1~6月份某院使用人血白蛋白的5257份病例并统计分析，随机抽取每月30份共180份病例进行合理性评价。结果：该院白蛋白使用率为11.8%，白蛋白费用占药品总费用9.4%。180份点评的病例中合理率46.1%。结论：该院人血白蛋白使用存在一定的不合理性，建议制定人血白蛋白合理使用规范，促进临床合理用药。
|
| 关 键 词： | 人血白蛋白；合理用药；分析 |
| 收稿时间： | 2015-09-18 |
| 修稿时间： | 2015-10-09 |
Clinical Application Investigation and Rationality Analysis of Human Serum Albumin |
| |
| HANG Yong-fu,ZHENG Xiao-xian,ZHANG Yan,LI Yun,QIN Qiong,GONG Xiao-ying,BAO Jian-an and JIN Hong-bin. Clinical Application Investigation and Rationality Analysis of Human Serum Albumin[J]. Pharmacertical and Clinical Research, 2015, 23(6): 581-583 |
| |
| Authors: | HANG Yong-fu ZHENG Xiao-xian ZHANG Yan LI Yun QIN Qiong GONG Xiao-ying BAO Jian-an JIN Hong-bin |
| |
| Affiliation: | Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China,Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China,Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China,Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China,Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China,Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China,Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China and Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou 215006, China |
| |
| Abstract: | Objective: To investigate the clinical use of human serum albumin (HAS) as the basis and reference for building up a system to manage and monitor the use of HSA. Methods: A retrospective study that included 5257 patients receiving HSA in our hospital was performed from January to June 2013, 180 records were selected randomly and evaluated for rationality. Results: The utilization rate of HSA was 11.8%, HSA cost account for 9.4% of the total cost of all drugs, the rational rate of HSA use was 46.1%. Conclusion: There was some irrational use of HSA in this hospital; a system to manage and monitor the use of HSA should be established to promote rational drug use. |
| |
| Keywords: | Human serum albumin Rational use of drugs Analysis |
|
| 点击此处可从《药学与临床研究》浏览原始摘要信息 |
|
点击此处可从《药学与临床研究》下载全文 |
|
